Quorum Quenching and Quorum-Sensing Interference in Pseudomonas aeruginosa: Molecular Mechanisms, Host Protection, and Translational Barriers
4 affiliations
- 1Department of Epidemiology and Health Statistics, School of Public Health, Xi’an Jiaotong University Health Science Center, No. 76 Yanta West Road, Xi’an 710061, China
- 2Infection Control Office, Xi’an Public Health Center (Xi’an Emergency Medical Center), Xi’an 710200, China
- 3Yunnan Key Laboratory of Cross-Border Infectious Disease Prevention and New Drug Development, Kunming Medical University, Kunming 650500, China
- 4Yunnan Provincial Key Laboratory of Public Health and Biosafety & School of Public Health, Kunming Medical University, Kunming 650500, China
Abstract
Quorum sensing (QS) coordinates virulence expression, biofilm-associated behavior, and persistence in Pseudomonas aeruginosa, making its signaling network a potential target for adjunctive anti-virulence therapy. Quorum quenching (QQ) directly degrades, modifies, or sequesters signaling molecules, whereas broader QS interference encompasses inhibition of signal synthesis, receptor antagonism, and disruption of downstream regulatory interactions. Experimental studies of N-acyl-homoserine lactone (AHL)-degrading enzymes and PqsR antagonists have demonstrated suppression of selected virulence-associated phenotypes, with several infection models showing reductions in host injury or persistence-associated outcomes. The PqsE–RhlR regulatory interface has gained substantial molecular and genetic support as a distinct intervention target, but its pharmacological development remains limited. Responses to QS interference vary with bacterial strain, regulatory network adaptation, environmental conditions, and infection stage. Reductions in virulence-factor production or biofilm biomass do not consistently correspond to bacterial clearance or host protection. Available human studies involving agents with proposed QS-modulatory activity have not established clinical benefits specifically attributable to QS inhibition. Clinical translation requires validated target engagement, efficacy assessment in established and polymicrobial infections, and characterization of delivery, pharmacological exposure, safety, and resistance evolution.
Related
- D-enantiomeric β-casein 197 disrupts biofilm-associated infection of MDR Pseudomonas aeruginosa and Acinetobacter baumannii through superior LPS binding and host cell protection
- Expression of ExsA in trans Confers Type III Secretion System-Dependent Cytotoxicity on Noncytotoxic Pseudomonas aeruginosa Cystic Fibrosis Isolates
- Role of manganese superoxide dismutase in a mucoid isolate of Pseudomonas aeruginosa: adaptation to oxidative stress
- Cell Death of Human Polymorphonuclear Neutrophils Induced by a Pseudomonas aeruginosa Cystic Fibrosis Isolate Requires a Functional Type III Secretion System
- Mechanical compression activates cAMP signaling in Pseudomonas aeruginosa
BibTeX
@article{zhao2026quorum,
title = {{Quorum Quenching and Quorum-Sensing Interference in Pseudomonas aeruginosa: Molecular Mechanisms, Host Protection, and Translational Barriers}},
author = {Xin Zhao and Wei Zou and Leilei Pei},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = oct,
doi = {10.3390/ijms27219439},
url = {https://www.mdpi.com/1422-0067/27/21/9439},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Quorum Quenching and Quorum-Sensing Interference in Pseudomonas aeruginosa: Molecular Mechanisms, Host Protection, and Translational Barriers
AU - Xin Zhao
AU - Wei Zou
AU - Leilei Pei
PY - 2026
DA - 2026/10/23
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27219439
UR - https://www.mdpi.com/1422-0067/27/21/9439
AB - Quorum sensing (QS) coordinates virulence expression, biofilm-associated behavior, and persistence in Pseudomonas aeruginosa, making its signaling network a potential target for adjunctive anti-virulence therapy. Quorum quenching (QQ) directly degrades, modifies, or sequesters signaling molecules, whereas broader QS interference encompasses inhibition of signal synthesis, receptor antagonism, and disruption of downstream regulatory interactions. Experimental studies of N-acyl-homoserine lactone (AHL)-degrading enzymes and PqsR antagonists have demonstrated suppression of selected virulence-associated phenotypes, with several infection models showing reductions in host injury or persistence-associated outcomes. The PqsE–RhlR regulatory interface has gained substantial molecular and genetic support as a distinct intervention target, but its pharmacological development remains limited. Responses to QS interference vary with bacterial strain, regulatory network adaptation, environmental conditions, and infection stage. Reductions in virulence-factor production or biofilm biomass do not consistently correspond to bacterial clearance or host protection. Available human studies involving agents with proposed QS-modulatory activity have not established clinical benefits specifically attributable to QS inhibition. Clinical translation requires validated target engagement, efficacy assessment in established and polymicrobial infections, and characterization of delivery, pharmacological exposure, safety, and resistance evolution.
SN - 1422-0067
ER -